Silverstein Jonathan
SEC-identified person · CIK 1171005 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Arcutis Biotherapeutics, Inc. ARQT | Director | filed 2020 - 2020 |
| Restorbio, Inc. TORC | Director | filed 2018 - 2020 |
| Avedro INC AVDR | Director | filed 2019 - 2019 |
| Glaukos Corp GKOS | Director | filed 2015 - 2018 |
| Scpharmaceuticals Inc. SCPH | Director | filed 2017 - 2017 |
| Rhythm Pharmaceuticals, INC. SRYTM | Director | filed 2017 - 2017 |
| Roka Bioscience, Inc. ROKA | Director | filed 2014 - 2016 |
| Audentes Therapeutics, Inc. BOLD | Director | filed 2016 - 2016 |
| Intercept Pharmaceuticals, INC. ICPT | Director | filed 2012 - 2015 |
| Relypsa Inc RLYP | Director | filed 2013 - 2013 |
| Nxstage Medical, Inc. NXTM | Director | filed 2008 - 2010 |
| Insulet Corp PODD | Director | filed 2007 - 2007 |
| Avanir Pharmaceuticals, INC. AVNR | Director | filed 2006 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.